What is Frequency Therapeutics Inc (KRRO) stock price today?

Frequency Therapeutics Inc (KRRO) currently trades at $13.49 per share. The stock has a market capitalization of $196.07M and a P/E ratio of —x.

Is KRRO stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Frequency Therapeutics Inc has a Smart Value Score of 21/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Frequency Therapeutics Inc's revenue and earnings?

Frequency Therapeutics Inc has trailing twelve-month (TTM) revenue of $6.39M with profit margins of 0.00%. Earnings per share (EPS) is $-12.48.

KRRO

Frequency Therapeutics Inc

NASDAQ: KRRO · HEALTHCARE · BIOTECHNOLOGY

$13.49

+6.98% today

Updated 2026-04-30

Market cap

$196.07M

P/E ratio

—

P/S ratio

30.68x

EPS (TTM)

$-12.48

Dividend yield

—

52W range

$5 – $56

Volume

0.2M

Market cap

$196.07M

P/E ratio

—

P/S ratio

30.68x

EPS (TTM)

$-12.48

Dividend yield

—

52W range

$5 – $56

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.7

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$20.00

+48.26%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy5 Buy3 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-17.79M

- Revenue declining -43.10% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$2.27M	$6.39M	$6.39M
Net income	$-58.03M	$-81.17M	$-83.58M	$-117.26M	$-50.04M
EPS	—	—	—	—	$-12.48
Free cash flow	$-58.86M	$-75.12M	$-77.98M	$-79.08M	$-17.79M
Profit margin	—	—	-3,680.36%	-1,834.48%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
KRRO	$196.07M	21	3.7	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Frequency Therapeutics Inc trades at $13.49. Our Smart Value Score of 21/100 indicates the stock is weak. TTM revenue stands at $6.39M.

Frequently asked questions

What is Frequency Therapeutics Inc's stock price?

Frequency Therapeutics Inc (KRRO) trades at $13.49.

Is Frequency Therapeutics Inc overvalued?

Smart Value Score 21/100 (Grade F, Strong Sell).

What is the price target of Frequency Therapeutics Inc (KRRO)?

The analyst target price is $20.00, representing +48.3% upside from the current price of $13.49.

What is Frequency Therapeutics Inc's revenue?

TTM revenue is $6.39M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio30.68x

ROE-110.70%

Beta2.43

50D MA$12.15

200D MA$18.70

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

KRRO vs LLY →KRRO vs JNJ →KRRO vs ABBV →Stock screener →